Table of Contents

CHAPTER 1 MARKET OVERVIEW

• 1.1 Market Definition and Segment
  • 1.1.1 Product Definition
  • 1.1.2 Product Type
  • 1.1.3 End-Use
  • 1.1.4 Marketing Channel
• 1.2 Major Regions
  • 1.2.1 Europe Market Size and Growth

Figure Europe Non-Insulin Therapies for Diabetes Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Europe Non-Insulin Therapies for Diabetes Market Forecast and Growth Rate, 2020E-2025F (Million USD)

• 1.2.2 America Market Size and Growth

Figure America Non-Insulin Therapies for Diabetes Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure America Non-Insulin Therapies for Diabetes Market Forecast and Growth Rate, 2020E-2025F (Million USD)

• 1.2.3 Asia Market Size and Growth

Figure Asia Non-Insulin Therapies for Diabetes Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure AsiaNon-Insulin Therapies for Diabetes Market Forecast and Growth Rate, 2020E-2025F (Million USD)

• 1.2.4 Oceania Market Size and Growth

Figure Oceania Non-Insulin Therapies for Diabetes Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Oceania Non-Insulin Therapies for Diabetes Market Forecast and Growth Rate, 2020E-2025F (Million USD)

• 1.2.5 Africa Market Size and Growth

Figure Africa Non-Insulin Therapies for Diabetes Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Africa Non-Insulin Therapies for Diabetes Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

• 2.1 Global Production Overview

Table Global Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 2.2 Global Consumption Overview

Table Global Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 2.3 Global Production by Type

Table Global Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Figure Global Non-Insulin Therapies for Diabetes Revenue Share by Type in 2020 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Figure Global Non-Insulin Therapies for Diabetes Production Volume Share by Type in 2020 (Volume)

• 2.4 Global Consumption by End-Use

Table Global Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Global Non-Insulin Therapies for Diabetes Consumption Value Share by End-Use in 2020 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Global Non-Insulin Therapies for Diabetes Consumption Volume Share by End-Use in 2020 (Volume)

• 2.5 Global Consumption by Region

Table Global Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 Europe MARKET SEGMENTATION

• 3.1 Europe Production Overview

Table Europe Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 3.2 Europe Consumption Overview

Table Europe Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 3.3 Europe Production by Type

Table Europe Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Figure Europe Non-Insulin Therapies for Diabetes Revenue Share by Type in 2020 (Million USD)

Table Europe Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Figure Europe Non-Insulin Therapies for Diabetes Production Volume Share by Type in 2020 (Volume)

• 3.4 Europe Consumption by End-Use

Table Europe Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Europe Non-Insulin Therapies for Diabetes Consumption Value Share by End-Use in 2020 (Million USD)

Table Europe Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Europe Non-Insulin Therapies for Diabetes Consumption Volume Share by End-Use in 2020 (Volume)

• 3.5 Europe Consumption by Region

Table Europe Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Europe Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

• 4.1 America Production Overview

Table America Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 4.2 America Consumption Overview

Table America Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 4.3 America Production by Type

Table America Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Figure America Non-Insulin Therapies for Diabetes Revenue Share by Type in 2020 (Million USD)

Table America Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Figure America Non-Insulin Therapies for Diabetes Production Volume Share by Type in 2020 (Volume)

• 4.4 America Consumption by End-Use

Table America Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Figure America Non-Insulin Therapies for Diabetes Consumption Value Share by End-Use in 2020 (Million USD)

Table America Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Figure America Non-Insulin Therapies for Diabetes Consumption Volume Share by End-Use in 2020 (Volume)

• 4.5 America Consumption by Region

Table America Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table America Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

• 5.1 Asia Production Overview

Table Asia Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 5.2 Asia Consumption Overview

Table Asia Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 5.3 Asia Production by Type

Table Asia Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Figure Asia Non-Insulin Therapies for Diabetes Revenue Share by Type in 2020 (Million USD)

Table Asia Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Figure Asia Non-Insulin Therapies for Diabetes Production Volume Share by Type in 2020 (Volume)

• 5.4 Asia Consumption by End-Use

Table Asia Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Asia Non-Insulin Therapies for Diabetes Consumption Value Share by End-Use in 2020 (Million USD)

Table Asia Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Asia Non-Insulin Therapies for Diabetes Consumption Volume Share by End-Use in 2020 (Volume)

• 5.5 Asia Consumption by Region

Table Asia Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Asia Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

• 6.1 Oceania Production Overview

Table Oceania Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 6.2 Oceania Consumption Overview

Table Oceania Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 6.3 Oceania Production by Type

Table Oceania Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Figure Oceania Non-Insulin Therapies for Diabetes Revenue Share by Type in 2020 (Million USD)

Table Oceania Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Figure Oceania Non-Insulin Therapies for Diabetes Production Volume Share by Type in 2020 (Volume)

• 6.4 Oceania Consumption by End-Use

Table Oceania Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Oceania Non-Insulin Therapies for Diabetes Consumption Value Share by End-Use in 2020 (Million USD)

Table Oceania Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Oceania Non-Insulin Therapies for Diabetes Consumption Volume Share by End-Use in 2020 (Volume)

• 6.5 Oceania Consumption by Region

Table Oceania Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Oceania Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

• 7.1 Africa Production Overview

Table Africa Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 7.2 Africa Consumption Overview

Table Africa Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 7.3 Africa Production by Type

Table Africa Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Figure Africa Non-Insulin Therapies for Diabetes Revenue Share by Type in 2020 (Million USD)

Table Africa Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Figure Africa Non-Insulin Therapies for Diabetes Production Volume Share by Type in 2020 (Volume)

• 7.4 Africa Consumption by End-Use

Table Africa Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Africa Non-Insulin Therapies for Diabetes Consumption Value Share by End-Use in 2020 (Million USD)

Table Africa Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Africa Non-Insulin Therapies for Diabetes Consumption Volume Share by End-Use in 2020 (Volume)

• 7.5 Africa Consumption by Region

Table Africa Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Africa Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

• 8.1 Global Non-Insulin Therapies for Diabetes Production Forecast

Figure Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast 2020E-2025F (Million USD)

Figure Global Non-Insulin Therapies for Diabetes Production Volume and Growth Rate Forecast 2020E-2025F (Volume)

• 8.2 Global Non-Insulin Therapies for Diabetes Forecast by Type

Table Global Non-Insulin Therapies for Diabetes Revenue by Type, 2020E-2025F (Million USD)

Figure Global Non-Insulin Therapies for Diabetes Revenue Share by Type in 2025 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Production Volume by Type, 2020E-2025F (Volume)

Figure Global Non-Insulin Therapies for Diabetes Production Volume Share by Type in 2025 (Volume)

• 8.3 Global Non-Insulin Therapies for Diabetes Forecast by End-Use (2020E-2025F)

Table Global Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2020E-2025F (Million USD)

Figure Global Non-Insulin Therapies for Diabetes Consumption Value Share by End-Use in 2025 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2020E-2025F (Volume)

• 8.4 Global Non-Insulin Therapies for Diabetes Forecast by Region (2020E-2025F)

Table Global Non-Insulin Therapies for Diabetes Consumption Value by Region, 2020E-2025F (Million USD)

Figure Global Non-Insulin Therapies for Diabetes Consumption Value Share by Region in 2025 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2020E-2025F (Volume)

Figure Global Non-Insulin Therapies for Diabetes Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

• 9.1 GSK
  • 9.1.1 GSK Profile

Table GSK Overview List

• 9.1.2 GSK Products & Services
• 9.1.3 GSK Company Dynamics & News
• 9.1.4 GSK Business Operation Conditions

Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.2 Eli Lilly
  • 9.2.1 Eli Lilly Profile

Table Eli Lilly Overview List

• 9.2.2 Eli Lilly Products & Services
• 9.2.3 Eli Lilly Company Dynamics & News
• 9.2.4 Eli Lilly Business Operation Conditions

Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.3 Sumitomo Dainippon Pharma
  • 9.3.1 Sumitomo Dainippon Pharma Profile

Table Sumitomo Dainippon Pharma Overview List

• 9.3.2 Sumitomo Dainippon Pharma Products & Services
• 9.3.3 Sumitomo Dainippon Pharma Company Dynamics & News
• 9.3.4 Sumitomo Dainippon Pharma Business Operation Conditions

Table Business Operation of Sumitomo Dainippon Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.4 Intarcia Therapeutics
  • 9.4.1 Intarcia Therapeutics Profile

Table Intarcia Therapeutics Overview List

• 9.4.2 Intarcia Therapeutics Products & Services
• 9.4.3 Intarcia Therapeutics Company Dynamics & News
• 9.4.4 Intarcia Therapeutics Business Operation Conditions

Table Business Operation of Intarcia Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.5 Servier
  • 9.5.1 Servier Profile

Table Servier Overview List

• 9.5.2 Servier Products & Services
• 9.5.3 Servier Company Dynamics & News
• 9.5.4 Servier Business Operation Conditions

Table Business Operation of Servier (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.6 Jiangsu Hansoh Pharmaceutical
  • 9.6.1 Jiangsu Hansoh Pharmaceutical Profile

Table Jiangsu Hansoh Pharmaceutical Overview List

• 9.6.2 Jiangsu Hansoh Pharmaceutical Products & Services
• 9.6.3 Jiangsu Hansoh Pharmaceutical Company Dynamics & News
• 9.6.4 Jiangsu Hansoh Pharmaceutical Business Operation Conditions

Table Business Operation of Jiangsu Hansoh Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.7 Novo Nordisk
  • 9.7.1 Novo Nordisk Profile

Table Novo Nordisk Overview List

• 9.7.2 Novo Nordisk Products & Services
• 9.7.3 Novo Nordisk Company Dynamics & News
• 9.7.4 Novo Nordisk Business Operation Conditions

Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.8 Emisphere
  • 9.8.1 Emisphere Profile

Table Emisphere Overview List

• 9.8.2 Emisphere Products & Services
• 9.8.3 Emisphere Company Dynamics & News
• 9.8.4 Emisphere Business Operation Conditions

Table Business Operation of Emisphere (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.9 Uni-Bio Science Group
  • 9.9.1 Uni-Bio Science Group Profile

Table Uni-Bio Science Group Overview List

• 9.9.2 Uni-Bio Science Group Products & Services
• 9.9.3 Uni-Bio Science Group Company Dynamics & News
• 9.9.4 Uni-Bio Science Group Business Operation Conditions

Table Business Operation of Uni-Bio Science Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.10 Takeda
  • 9.10.1 Takeda Profile

Table Takeda Overview List

• 9.10.2 Takeda Products & Services
• 9.10.3 Takeda Company Dynamics & News
• 9.10.4 Takeda Business Operation Conditions

Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.11 3SBio
  • 9.11.1 3SBio Profile

Table 3SBio Overview List

• 9.11.2 3SBio Products & Services
• 9.11.3 3SBio Company Dynamics & News
• 9.11.4 3SBio Business Operation Conditions

Table Business Operation of 3SBio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.12 Merck
  • 9.12.1 Merck Profile

Table Merck Overview List

• 9.12.2 Merck Products & Services
• 9.12.3 Merck Company Dynamics & News
• 9.12.4 Merck Business Operation Conditions

Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)

• 9.13 Dong-A Pharmaceutical
  • 9.13.1 Dong-A Pharmaceutical Profile

Table Dong-A Pharmaceutical Overview List

• 9.13.2 Dong-A Pharmaceutical Products & Services
• 9.13.3 Dong-A Pharmaceutical Company Dynamics & News
• 9.13.4 Dong-A Pharmaceutical Business Operation Conditions

Table Business Operation of Dong-A Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.14 Luye Pharma Group
  • 9.14.1 Luye Pharma Group Profile

Table Luye Pharma Group Overview List

• 9.14.2 Luye Pharma Group Products & Services
• 9.14.3 Luye Pharma Group Company Dynamics & News
• 9.14.4 Luye Pharma Group Business Operation Conditions

Table Business Operation of Luye Pharma Group (Sales Revenue, Cost, Gross Margin)

• 9.15 Eurofarma
  • 9.15.1 Eurofarma Profile

Table Eurofarma Overview List

• 9.15.2 Eurofarma Products & Services
• 9.15.3 Eurofarma Company Dynamics & News
• 9.15.4 Eurofarma Business Operation Conditions

Table Business Operation of Eurofarma (Sales Revenue, Cost, Gross Margin)

• 9.16 Geropharm
  • 9.16.1 Geropharm Profile

Table Geropharm Overview List

• 9.16.2 Geropharm Products & Services
• 9.16.3 Geropharm Company Dynamics & News
• 9.16.4 Geropharm Business Operation Conditions

Table Business Operation of Geropharm (Sales Revenue, Cost, Gross Margin)

• 9.17 Alkem Labs
  • 9.17.1 Alkem Labs Profile

Table Alkem Labs Overview List

• 9.17.2 Alkem Labs Products & Services
• 9.17.3 Alkem Labs Company Dynamics & News
• 9.17.4 Alkem Labs Business Operation Conditions

Table Business Operation of Alkem Labs (Sales Revenue, Cost, Gross Margin)

• 9.18 SatRx
  • 9.18.1 SatRx Profile

Table SatRx Overview List

• 9.18.2 SatRx Products & Services
• 9.18.3 SatRx Company Dynamics & News
• 9.18.4 SatRx Business Operation Conditions

Table Business Operation of SatRx (Sales Revenue, Cost, Gross Margin)

• 9.19 Pfizer
  • 9.19.1 Pfizer Profile

Table Pfizer Overview List

• 9.19.2 Pfizer Products & Services
• 9.19.3 Pfizer Company Dynamics & News
• 9.19.4 Pfizer Business Operation Conditions

Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)

• 9.20 Jiangsu Hengrui Medicine
  • 9.20.1 Jiangsu Hengrui Medicine Profile

Table Jiangsu Hengrui Medicine Overview List

• 9.20.2 Jiangsu Hengrui Medicine Products & Services
• 9.20.3 Jiangsu Hengrui Medicine Company Dynamics & News
• 9.20.4 Jiangsu Hengrui Medicine Business Operation Conditions

Table Business Operation of Jiangsu Hengrui Medicine (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

• 10.1 Key Company Market Share

Table Global Non-Insulin Therapies for Diabetes Sales Revenue 2015-2020E, by Companies, in USD Million

Table Global Non-Insulin Therapies for Diabetes Sales Revenue Share, 2015-2020E, by Companies, in USD

Table Global Non-Insulin Therapies for Diabetes Sales Volume by Companies, 2015-2020E (Volume)

Table Global Non-Insulin Therapies for Diabetes Sales Volume Share by Companies, 2015-2020E (Volume)

• 10.2 Regional Market Concentration

Figure Europe Non-Insulin Therapies for Diabetes Market Concentration Ratio in 2020E

Figure America Non-Insulin Therapies for Diabetes Market Concentration Ratio in 2020E

Figure Asia Non-Insulin Therapies for Diabetes Market Concentration Ratio in 2020E

Figure Oceania Non-Insulin Therapies for Diabetes Market Concentration Ratio in 2020E

Figure Africa Non-Insulin Therapies for Diabetes Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON Non-Insulin Therapies for Diabetes INDUSTRY

• 11.1 Impact on Industry Upstream
• 11.2 Impact on Industry Downstream
• 11.3 Impact on Industry Channels
• 11.4 Impact on Industry Competition
• 11.5 Impact on Industry Obtain Employment

PART 12 Non-Insulin Therapies for Diabetes INDUSTRY SUMMARY & CONCLUSION

List of Table

Table Global Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Table Global Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Table Global Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Global Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

Table Europe Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table Europe Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table Europe Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Table Europe Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Table Europe Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Table Europe Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Table Europe Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Europe Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

Table America Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table America Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table America Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Table America Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Table America Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Table America Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Table America Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table America Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

Table Asia Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table Asia Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table Asia Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Table Asia Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Table Asia Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Table Asia Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Table Asia Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Asia Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

Table Oceania Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table Oceania Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table Oceania Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Table Oceania Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Table Oceania Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Table Oceania Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Table Oceania Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Oceania Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

Table Africa Non-Insulin Therapies for Diabetes Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table Africa Non-Insulin Therapies for Diabetes Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table Africa Non-Insulin Therapies for Diabetes Revenue by Type, 2015-2020 (Million USD)

Table Africa Non-Insulin Therapies for Diabetes Production Volume by Type, 2015-2020 (Volume)

Table Africa Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2015-2020 (Million USD)

Table Africa Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2015-2020 (Volume)

Table Africa Non-Insulin Therapies for Diabetes Consumption Value by Region, 2015-2020 (Million USD)

Table Africa Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2015-2020 (Volume)

Table Global Non-Insulin Therapies for Diabetes Revenue by Type, 2020E-2025F (Million USD)

Table Global Non-Insulin Therapies for Diabetes Production Volume by Type, 2020E-2025F (Volume)

Table Global Non-Insulin Therapies for Diabetes Consumption Value by End-Use, 2020E-2025F (Million USD)

Table Global Non-Insulin Therapies for Diabetes Consumption Volume by End-Use, 2020E-2025F (Volume)

Table Global Non-Insulin Therapies for Diabetes Consumption Value by Region, 2020E-2025F (Million USD)

Table Global Non-Insulin Therapies for Diabetes Consumption Volume by Region, 2020E-2025F (Volume)

Table GSK Overview List

Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sumitomo Dainippon Pharma Overview List

Table Business Operation of Sumitomo Dainippon Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Intarcia Therapeutics Overview List

Table Business Operation of Intarcia Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Servier Overview List

Table Business Operation of Servier (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Jiangsu Hansoh Pharmaceutical Overview List

Table Business Operation of Jiangsu Hansoh Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novo Nordisk Overview List

Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Emisphere Overview List

Table Business Operation of Emisphere (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Uni-Bio Science Group Overview List

Table Business Operation of Uni-Bio Science Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Overview List

Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 3SBio Overview List

Table Business Operation of 3SBio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)

Table Dong-A Pharmaceutical Overview List

Table Business Operation of Dong-A Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Luye Pharma Group Overview List

Table Business Operation of Luye Pharma Group (Sales Revenue, Cost, Gross Margin)

Table Eurofarma Overview List

Table Business Operation of Eurofarma (Sales Revenue, Cost, Gross Margin)

Table Geropharm Overview List

Table Business Operation of Geropharm (Sales Revenue, Cost, Gross Margin)

Table Alkem Labs Overview List

Table Business Operation of Alkem Labs (Sales Revenue, Cost, Gross Margin)

Table SatRx Overview List

Table Business Operation of SatRx (Sales Revenue, Cost, Gross Margin)

Table Pfizer Overview List

Table Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)

Table Jiangsu Hengrui Medicine Overview List

Table Business Operation of Jiangsu Hengrui Medicine (Sales Revenue, Cost, Gross Margin)

Table Global Non-Insulin Therapies for Diabetes Sales Revenue 2015-2020E, by Companies, in USD Million

Table Global Non-Insulin Therapies for Diabetes Sales Revenue Share, 2015-2020E, by Companies, in USD

Table Global Non-Insulin Therapies for Diabetes Sales Volume by Companies, 2015-2020E (Volume)

Table Global Non-Insulin Therapies for Diabetes Sales Volume Share by Companies, 2015-2020E (Volume)

List of Figure

Figure Europe Non-Insulin Therapies for Diabetes Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Europe Non-Insulin Therapies for Diabetes Mar

Summary

The global Non-Insulin Therapies for Diabetes market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
.
Market Segment as follows:

Key Companies
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine

Key Types
Alpha-glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides / Meglitinides
GLP-1 Analogs / GLP-1 Agonists
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Sulfonylureas
Thiazolidinediones
Others

Key End-Use
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

This report can be dispatched within 24-48 Hours.